Fagan Associates’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,170
Closed -$938K 118
2019
Q2
$938K Buy
+6,170
New +$938K 0.38% 67